These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3481088)

  • 21. Characteristics of the adaptive aspects of the dopaminergic system.
    Davila R; Zumarraga M; Friedhoff AJ; Miller JC
    Psychopharmacol Bull; 1988; 24(3):338-40. PubMed ID: 3153490
    [No Abstract]   [Full Text] [Related]  

  • 22. An evaluation of debrisoquine and mefruside in the treatment of hypertension in African and Indian patients.
    Seedat YK
    Curr Med Res Opin; 1980; 7(1):68-72. PubMed ID: 7428417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma HVA levels following debrisoquine administration do not reflect cerebral dopamine loss in early Parkinson's disease.
    Rose S; Hindmarsh JG; Steiger MJ; Bhatt M; Quinn NP; Jenner P; Marsden CD
    Clin Neuropharmacol; 1994 Jun; 17(3):260-9. PubMed ID: 9316671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of plasma homovanillic acid as an index of brain dopamine function.
    Kendler KS; Hsieh JY; Davis KL
    Psychopharmacol Bull; 1982 Oct; 18(4):152-5. PubMed ID: 7156280
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma HVA in adults with mental retardation and stereotyped behavior: biochemical evidence for a dopamine deficiency model.
    Lewis MH; Bodfish JW; Powell SB; Wiest K; Darling M; Golden RN
    Am J Ment Retard; 1996 Jan; 100(4):413-8. PubMed ID: 8718995
    [No Abstract]   [Full Text] [Related]  

  • 26. Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement.
    Nibuya M; Kanba S; Sekiya U; Suzuki E; Matsuo Y; Kinoshita N; Shintani F; Yagi G; Asai M
    Biol Psychiatry; 1995 Jul; 38(1):50-6. PubMed ID: 7548472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
    Hietala J; Koulu M; Scheinin M; Syvälahti E
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):451-4. PubMed ID: 3935892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome].
    Takano K; Ishiguro T
    Seishin Shinkeigaku Zasshi; 1993; 95(1):1-29. PubMed ID: 7685527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant impact of MTHFR C677T polymorphism on plasma homovanillic acid (HVA) levels among alcohol-dependent patients.
    Lutz UC; Batra A; Wiatr G; Machicao F; Kolb W; Maurer S; Buchkremer G; Köhnke MD
    Addict Biol; 2007 Mar; 12(1):100-5. PubMed ID: 17407503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased catecholamine output in the hypertensive fawn-hooded rat.
    Magro AM; Rudofsky UH; Gilboa N; Seegal R
    Lab Anim Sci; 1986 Dec; 36(6):646-9. PubMed ID: 3821054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system.
    Bock N; Moll GH; Wicker M; Pilz J; Rüther E; Banaschewski T; Huether G; Rothenberger A
    Pharmacopsychiatry; 2004 Jul; 37(4):163-7. PubMed ID: 15467972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma homovanillic acid correlates inversely with history of learning problems in healthy volunteer and personality disordered subjects.
    Coccaro EF; Hirsch SL; Stein MA
    Psychiatry Res; 2007 Jan; 149(1-3):297-302. PubMed ID: 17113158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinergic and dopaminergic mechanisms in Tourette syndrome.
    Stahl SM; Berger PA
    Adv Neurol; 1982; 35():141-50. PubMed ID: 6959486
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms.
    Dávila R; Zumárraga M; Basterreche N; Arrúe A; Anguiano JB
    Psychiatry Res; 2007 May; 151(1-2):163-8. PubMed ID: 17434602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the dopaminergic lesion in Parkinson's disease by CSF markers.
    LeWitt PA
    Adv Neurol; 1993; 60():544-7. PubMed ID: 8420188
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia.
    Yamada K; Kanba S; Ohnishi K; Ashikari I; Yagi G; Asai M
    Biol Psychiatry; 1997 May; 41(10):1062-4. PubMed ID: 9129786
    [No Abstract]   [Full Text] [Related]  

  • 37. Inter- and intra-individual variability in the levels of plasma homovanillic acid in schizophrenic patients.
    Zumárraga M; Dávila R; González-Torres MA; Anguiano JB; Zabalo MJ; Basterreche N; Arrúe A; Zamalloa MI; Guimón J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):713-9. PubMed ID: 17291661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects.
    Giltay EJ; Kho KH; Blansjaar BA; Verbeek MM; Geurtz PB; Geleijnse JM; Gooren LJ
    J Endocrinol; 2005 Oct; 187(1):109-16. PubMed ID: 16214946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal deprivation of neonatal rats produces enduring changes in dopamine function.
    Hall FS; Wilkinson LS; Humby T; Robbins TW
    Synapse; 1999 Apr; 32(1):37-43. PubMed ID: 10188636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for the importance of dopamine for prefrontal cortex functions early in life.
    Diamond A
    Philos Trans R Soc Lond B Biol Sci; 1996 Oct; 351(1346):1483-93; discussion 1494. PubMed ID: 8941960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.